Export

Amodiaquine + sulfadoxine + pyrimethamine
Essential medicine status
General description

INN
Amodiaquine + sulfadoxine + pyrimethamine
Medicine type
Chemical agent
EML status history
First added in 2019 (TRS 1021) for Malaria
Therapeutic equivalent for
Recommendations
Section
Antimalarial medicines > For chemoprevention
  • Oral > Solid: 76.5 mg (as hydrochloride) [3] + 250 mg + 12.5 mg [1] dispersible tablets in co-package; 153 mg (as hydrochloride) [3] + 500 mg + 25 mg [1] dispersible tablets in co-package
Indications